On November 6, 2015, the board of directors of FluoroPharma Medical, Inc. appointed each of Dr. Thomas H. Tulip and Austin Lewis as directors. Effective as of November 12, 2015, Dr. Joseph A. Pierro resigned as a director. The resignation of Dr. Pierro was not due to any disagreement on any matter relating to the company's operations, policies or practices.

Dr. Tulip joined the company as President in October of this year. W. Austin Lewis, IV currently serves as CEO, CFO, and a Director of PAID, Inc., as well as the CEO of Lewis Asset Management Corp.